Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Dermatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Dermatology Other
    Topical Cream Effective Against Cetuximab-Induced Acne-Like Rash: Presented at ESMO-GI - (DGDispatch)
    Study Characterises Eczema Patients Most at Risk for Dangerous Viral Infections - (DGNews)
    Topical Fluorouracil Reduces Number of Actinic Keratoses, Improves Skin Damage - (DGNews)
    Actinic Keratoses Responsible for More Cancer Types Than Once Believed - (DGNews)
    Oral Linezolid as Effective as Intravenous Vancomycin in Treating MRSA in Complicated Skin and Soft Tissue Infections: Presented at ECCMID - (DGDispatch)

    News archive

     Recent webcasts/CME - Dermatology Other
      The Prevention and Treatment of Pressure Ulcers
      Contemporary Options for the Management of Scars
      Pediatric and Adolescent Sports-Related Injuries and Ailments
      Surgery: Current Challenges in Surgery: Complicated Skin and Soft Tissue Infections
      The Wound Healing Process

      Webcasts/CME archive

       Recent cases - Dermatology Other
        A Patient with Prickling Boils
        Acute Generalized Exanthematous Pustulosis (AGEP) Triggered by a Spider Bite
        A 72-Year-Old Man with a Purpuric Rash
        The First Case of Isolated Facial Cutanenous Leishmaniasis in a Down Syndrome Infant: A Case Report and Review of the Literature
        Bullous Dermatosis

        Cases archive
          




        my personal edition > dermatology other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Palmitoyl Pentapeptide Challenges Retinol as a Treatment for Photo-aged Skin: Presented at WCD

        By Jill Stein
        Special to DG News

        PARIS, FRANCE -- July 3, 2002 -- Two teams of investigators say palmitoyl pentapeptide (Pal-KTTKS) is as effective as retinol in improving the effects of photo-aging but lacks the side effects often associated with retinol.

        The findings from two separate trials were presented here today at the 20th World Congress of Dermatology (WCD).

        The first study, conducted by Dr. Karl Lintner, with Sederma SA in Paris, France, and colleagues, examined the effects of palmitoyl pentapeptide 3 ppm versus retinol 700 ppm on photo-aged skin. This double-blind half-face study enrolled 16 healthy women. For four months, they applied a cream containing 700 ppm of retinol to the crow's feet area on one side of the face and the same base cream containing 3 ppm of palmitoyl pentapeptide to the other side of the face.

        Patients applied the creams once daily for the first two months of the trial, then twice daily during months 3 and 4.

        Significant improvement of the skin profile (determined by profilometry of wrinkle depth, length, volume, roughness) for patients using the peptide was observed at the two-month evaluation versus baseline with further improvement versus baseline after four months.

        Dermatological scoring as well as image analysis confirmed a decrease in overall roughness and deep facial wrinkles with both treatments after four months. Although skin thickness increased by an average of 9 percent after four months for both treatments, the two-month data suggested that palmitoyl pentapeptide thickened the skin about 1.5 times faster than retinol.

        Palmitoyl pentapeptide did not cause the inflammatory reactions frequently associated with retinol treatment.

        Overall, the results suggest that palmitoyl pentapeptide is as effective as retinol at regenerating the skin but without the irritation that often occurs secondary to retinoid use, Dr. Lintner said.

        Dr. Lintner and Dr. Jean Revuz, with Mondor Hospital in Paris and the current president of the WCD, presented the results of the second study, which examined the effects of palmitoyl pentapeptide 5 ppm on the structure of elastin and collagen IV in 49 women with photo-aged skin.

        Over the course of the four-month, blinded study, the women who used 5 ppm of palmitoyl pentapeptide had substantial improvements in skin roughness, wrinkle volume, and wrinkle depth. Skin biopsies conducted on six patients indicated that palmitoyl pentapeptide triggered growth in elastin and collagen IV and enhanced the structure of elastin and collagen IV.

        The researchers note that the peptide was not associated with any side effects and was "a safe and potent alternative to Retinoids in wrinkle repair."

        Palmitoyl pentapeptide is a lipophilic modified peptide that is presently being investigated as an anti-aging ingredient. The peptide was developed by Sederma SA and is being tested by Sederma and Procter & Gamble Company in Cincinnati, Ohio.

        Both studies were supported by Sederma SA.



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send